Cargando…

NAFLD-Associated HCC: Progress and Opportunities

Due to an increase in the obesity-associated metabolic syndrome of epidemic proportions, nonalcoholic fatty liver disease (NAFLD) is becoming a leading cause of hepatocellular carcinoma (HCC) in western countries. This presents added challenges, as NAFLD-associated HCC tends to present at an advance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geh, Daniel, Anstee, Quentin M, Reeves, Helen L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041650/ https://www.ncbi.nlm.nih.gov/pubmed/33854987 http://dx.doi.org/10.2147/JHC.S272213

Ejemplares similares

A PDCD1 Role in the Genetic Predisposition to NAFLD-HCC?
por: Eldafashi, Nardeen, et al.
Publicado: (2021)

The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC
por: Song, Qian, et al.
Publicado: (2022)

Resection of NAFLD-Associated HCC: Patient Selection and Reported Outcomes
por: Campani, Claudia, et al.
Publicado: (2020)

PPARs and Mitochondrial Metabolism: From NAFLD to HCC
por: Mello, Tommaso, et al.
Publicado: (2016)

Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesis
por: Jarvis, Helen, et al.
Publicado: (2022)

The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC
por: Rusu, Ioana, et al.
Publicado: (2022)

NAFLD-Related HCC: Focus on the Latest Relevant Preclinical Models
por: Fang, Jing, et al.
Publicado: (2023)

Targeting T Cell Subtypes for NAFLD and NAFLD-Related HCC Treatment: An Opinion
por: Zhang, Chunye, et al.
Publicado: (2021)

Prognostic accuracy of FIB‐4, NAFLD fibrosis score and APRI for NAFLD‐related events: A systematic review
por: Lee, Jenny, et al.
Publicado: (2021)

Harnessing neutrophil plasticity for HCC immunotherapy
por: Ramon-Gil, Erik, et al.
Publicado: (2023)

Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCC
por: Longo, Miriam, et al.
Publicado: (2021)

Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment
por: Dongiovanni, Paola, et al.
Publicado: (2013)

The Role of Oxidative Stress in NAFLD–NASH–HCC Transition—Focus on NADPH Oxidases
por: Gabbia, Daniela, et al.
Publicado: (2021)

Recent updates on the role of the gut-liver axis in the pathogenesis of NAFLD/NASH, HCC, and beyond
por: Ohtani, Naoko, et al.
Publicado: (2023)

NAFLD and MAFLD as emerging causes of HCC: A populational study
por: Myers, Shuna, et al.
Publicado: (2021)

NAFLD as a risk factor for HCC: new rules of engagement?
por: Masuzaki, Ryota, et al.
Publicado: (2016)

Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC
por: Kim, Hyunmi, et al.
Publicado: (2021)

Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other Etiologies
por: Pal Chaudhary, Surendra, et al.
Publicado: (2023)

Weighing the benefits of hepatocellular carcinoma surveillance against potential harms
por: Geh, Daniel, et al.
Publicado: (2019)

Pharmacotherapies of NAFLD: updated opportunities based on metabolic intervention
por: Shao, Yaodi, et al.
Publicado: (2023)

The Role of Stem Cell Factor, Epidermal Growth Factor and Angiopoietin-2 in HBV, HCV, HCC and NAFLD
por: Radmanić, Leona, et al.
Publicado: (2022)

Tumor suppressor ZHX2 inhibits NAFLD–HCC progression via blocking LPL-mediated lipid uptake
por: Wu, Zhuanchang, et al.
Publicado: (2019)

LINC01468 drives NAFLD-HCC progression through CUL4A-linked degradation of SHIP2
por: Wang, Hongquan, et al.
Publicado: (2022)

Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression
por: Kotsari, Maria, et al.
Publicado: (2023)

Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies
por: Jarvis, Helen, et al.
Publicado: (2020)

Glucagon is associated with NAFLD inflammatory progression in type 2 diabetes, not with NAFLD fibrotic progression
por: Wang, Yuying, et al.
Publicado: (2021)

Nutrigenetics-based intervention approach for adults with non-alcoholic fatty liver disease (NAFLD): study protocol for a randomised controlled feasibility trial
por: Haigh, Laura, et al.
Publicado: (2021)

ER-residential Nogo-B accelerates NAFLD-associated HCC mediated by metabolic reprogramming of oxLDL lipophagy
por: Tian, Yuan, et al.
Publicado: (2019)

Signaling Nodes Associated with Endoplasmic Reticulum Stress during NAFLD Progression
por: Koo, Ja Hyun, et al.
Publicado: (2021)

Adaptive immunity: an emerging player in the progression of NAFLD
por: Sutti, Salvatore, et al.
Publicado: (2019)

Immunotherapy biomarkers for HCC: contemporary challenges and emerging opportunities
por: Kwee, Sandi, et al.
Publicado: (2022)

PPARα in the Epigenetic Driver Seat of NAFLD: New Therapeutic Opportunities for Epigenetic Drugs?
por: Theys, Claudia, et al.
Publicado: (2022)

Characterizing the mechanism behind the progression of NAFLD to hepatocellular carcinoma
por: Nahon, Pierre, et al.
Publicado: (2020)

Lipophagy Impairment Is Associated With Disease Progression in NAFLD
por: Carotti, Simone, et al.
Publicado: (2020)

MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice
por: Tessitore, Alessandra, et al.
Publicado: (2016)

Coffee Consumption and the Progression of NAFLD: A Systematic Review
por: Sewter, Rebecca, et al.
Publicado: (2021)

Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH
por: Wan, Xingyong, et al.
Publicado: (2016)

NAFLD in the Elderly
por: Alqahtani, Saleh A, et al.
Publicado: (2021)

Role of Serum Uric Acid and Ferritin in the Development and Progression of NAFLD
por: Lombardi, Rosa, et al.
Publicado: (2016)

Quality Standards for the Management of NAFLD: Consensus Recommendations from the British Association for the Study of the Liver (BASL) and British Society of Gastroenterology (BSG) NAFLD Special Interest Group
por: McPherson, Stuart, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oe20815mfl801t83d6recn9uct